Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
Focus on the basics
Portales et al
The direct defective of insulin signaling As has been mentioned, the proper modulators acting on different steps of the signaling pathway ensure appropriate biological responses to insulin in different tissues
The value of GSH as an immunopharmacologic agent is that it can finetune immune response in a disease-dependent and redox state-dependent manner which differs from typical broad-effect immunosuppressive treatments (Diotallevi et al., 2017) (Figure 3)
US$ 20.04
.jpg)
US$ 29.25
US$ 24.94
US$ 22.53
